PT1992622E - Derivado de 4-(3-benzoilaminofenil)-6,7-dimetoxi-2- etilaminoquinazolina - Google Patents

Derivado de 4-(3-benzoilaminofenil)-6,7-dimetoxi-2- etilaminoquinazolina Download PDF

Info

Publication number
PT1992622E
PT1992622E PT07714569T PT07714569T PT1992622E PT 1992622 E PT1992622 E PT 1992622E PT 07714569 T PT07714569 T PT 07714569T PT 07714569 T PT07714569 T PT 07714569T PT 1992622 E PT1992622 E PT 1992622E
Authority
PT
Portugal
Prior art keywords
methylaminoquinazoline
benzoylaminophenyl
dimethoxy
derivative
optionally substituted
Prior art date
Application number
PT07714569T
Other languages
English (en)
Inventor
Kazutomi Kusano
Kazuki Miyazaki
Yasutaka Takase
Osamu Asano
Manabu Shirato
Hisashi Wakita
Naoto Ishii
Takao Saeki
Original Assignee
Eisai R&D Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Man Co Ltd filed Critical Eisai R&D Man Co Ltd
Publication of PT1992622E publication Critical patent/PT1992622E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/78Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/84Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT07714569T 2006-02-21 2007-02-20 Derivado de 4-(3-benzoilaminofenil)-6,7-dimetoxi-2- etilaminoquinazolina PT1992622E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006043273 2006-02-21

Publications (1)

Publication Number Publication Date
PT1992622E true PT1992622E (pt) 2011-09-19

Family

ID=42137992

Family Applications (1)

Application Number Title Priority Date Filing Date
PT07714569T PT1992622E (pt) 2006-02-21 2007-02-20 Derivado de 4-(3-benzoilaminofenil)-6,7-dimetoxi-2- etilaminoquinazolina

Country Status (18)

Country Link
JP (1) JP4778550B2 (pt)
KR (1) KR101278852B1 (pt)
AT (1) ATE517875T1 (pt)
BR (1) BRPI0708098B8 (pt)
CY (1) CY1112554T1 (pt)
DK (1) DK1992622T3 (pt)
ES (1) ES2368089T3 (pt)
HK (1) HK1122025A1 (pt)
HR (1) HRP20110604T1 (pt)
IL (1) IL193322A (pt)
JO (1) JO2726B1 (pt)
MY (1) MY146275A (pt)
NZ (1) NZ569936A (pt)
PT (1) PT1992622E (pt)
RS (1) RS51969B (pt)
RU (1) RU2431632C2 (pt)
SI (1) SI1992622T1 (pt)
TW (1) TWI404709B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2678477A1 (en) 2007-02-16 2008-08-21 Eisai R&D Management Co., Ltd. Crystal, amorphous form and salt of methyl n-[3-(6,7-dimethoxy-2-methylaminoquinazolin-4-yl)phenyl]terephthalamic acid
ATE538102T1 (de) 2007-08-17 2012-01-15 Eisai R&D Man Co Ltd Verfahren zur herstellung eines chinazolinderivats
EP2202229B1 (en) 2007-08-17 2012-03-14 Eisai R&D Management Co., Ltd. Novel preparation for external use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR015966A1 (es) * 1997-10-17 2001-05-30 Smithkline Beecham Corp Uso de un compuesto inhibidor de pde4 para la preparacion de un medicamento util para el tratamiento de prurito
JPH11209350A (ja) 1998-01-26 1999-08-03 Eisai Co Ltd 含窒素複素環誘導体およびその医薬

Also Published As

Publication number Publication date
MY146275A (en) 2012-07-31
RU2008137654A (ru) 2010-03-27
DK1992622T3 (da) 2011-09-05
SI1992622T1 (sl) 2011-11-30
JPWO2007097317A1 (ja) 2009-07-16
BRPI0708098B8 (pt) 2021-05-25
NZ569936A (en) 2010-07-30
HRP20110604T1 (hr) 2011-09-30
HK1122025A1 (pt) 2009-05-08
ES2368089T3 (es) 2011-11-14
JP4778550B2 (ja) 2011-09-21
TW200812980A (en) 2008-03-16
ATE517875T1 (de) 2011-08-15
IL193322A (en) 2014-04-30
BRPI0708098B1 (pt) 2019-08-06
KR101278852B1 (ko) 2013-07-01
TWI404709B (zh) 2013-08-11
JO2726B1 (en) 2013-09-15
IL193322A0 (en) 2009-05-04
CY1112554T1 (el) 2016-02-10
RS51969B (en) 2012-02-29
KR20080094811A (ko) 2008-10-24
RU2431632C2 (ru) 2011-10-20
BRPI0708098A2 (pt) 2011-05-17

Similar Documents

Publication Publication Date Title
MY148703A (en) Polycyclic cinnamide derivatives
MY150507A (en) Polycyclic compound
HK1208868A1 (en) Novel ,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester-introduced phenyl group as substituents 2-
MY158982A (en) Heterocyclic compound
WO2009028629A1 (ja) 複素環化合物およびその用途
WO2007125547A3 (en) Novel process for statins and its pharmaceutically acceptable salts thereof
WO2005074603A3 (en) Aminobenzoxazoles as therapeutic agents
WO2009051670A3 (en) Oxylipin compounds for the treatment of ophthalmic conditions
MX342064B (es) Novedoso compuesto de imidazo-oxazina o sal del mismo.
WO2008019395A3 (en) Compounds for improving learning and memory
RS52255B (en) NALMEFEN HYDROCHLORIDE DIHYDRATE
WO2008057775A3 (en) Heterocyclic amide compounds useful as kinase inhibitors
WO2008140066A3 (en) Pyridone derivatives as p38a mapk inhibitors
WO2006039250A3 (en) Chemokine-binding heterocyclic compound salts, and methods of use thereof
GB201305247D0 (en) Amide Compounds
WO2009097515A3 (en) [a]-fused indole compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses
WO2006078984A3 (en) Uses of methylphenidate derivatives
CY1112554T1 (el) Παραγωγο 4-(3-βενζοϋλαμινοφαινυλ)-6,7-διμεθοξυ-2-μεθυλαμινοκιναζολινης
WO2010019203A8 (en) Antifungal agents
UA101954C2 (ru) Замещенные ароматические гетероциклические соединения как фунгициды
MY158199A (en) Substituted pyridine compound
MX2013007249A (es) Bifenoles halogenados como agentes antibacterianos.
TW200634000A (en) 2-(pyrazol-1-yl)pyridine derivatives
MX2010013184A (es) Compuesto heterocíclico.
WO2009111028A8 (en) Aurora kinase inhibitors